H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology.
Adult
Aged
Aged, 80 and over
Calcitriol
/ pharmacology
Cell Line, Tumor
Cell Proliferation
/ drug effects
Epigenesis, Genetic
/ drug effects
Female
Histones
/ metabolism
Humans
Kaplan-Meier Estimate
Lysine
/ metabolism
Methylation
/ drug effects
Middle Aged
Multivariate Analysis
Ovarian Neoplasms
/ genetics
Proportional Hazards Models
Receptors, Calcitriol
/ metabolism
Survival Analysis
1α,25(OH)2D3
calcitriol
cell proliferation
histone 3 lysine 4 trimethylation (H3K4me3)
histone modification
ovarian cancer
prognosis
vitamin D receptor
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
20 Mar 2020
20 Mar 2020
Historique:
received:
05
02
2020
revised:
12
03
2020
accepted:
18
03
2020
entrez:
5
4
2020
pubmed:
5
4
2020
medline:
6
1
2021
Statut:
epublish
Résumé
Posttranslational histone modification plays an important role in tumorigenesis. Histone modification is a dynamic response of chromatin to various signals, such as the exposure to calcitriol (1α,25(OH)
Identifiants
pubmed: 32245092
pii: ijms21062151
doi: 10.3390/ijms21062151
pmc: PMC7139961
pii:
doi:
Substances chimiques
Histones
0
Receptors, Calcitriol
0
Calcitriol
FXC9231JVH
Lysine
K3Z4F929H6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : China Scholarship Council
ID : CSC
Références
Nucleic Acids Res. 2011 Mar;39(6):2045-56
pubmed: 21088000
J Clin Oncol. 2007 Oct 1;25(28):4358-64
pubmed: 17906200
Br J Cancer. 2013 Feb 19;108(3):579-86
pubmed: 23370212
Cell. 2007 May 18;129(4):823-37
pubmed: 17512414
Best Pract Res Clin Obstet Gynaecol. 2012 Jun;26(3):337-45
pubmed: 22281513
Hum Pathol. 2012 Sep;43(9):1425-35
pubmed: 22406368
Endocr J. 2006 Apr;53(2):157-72
pubmed: 16618973
Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):355-70
pubmed: 20833329
Cell. 2007 Feb 23;128(4):693-705
pubmed: 17320507
Nat Rev Genet. 2002 Jun;3(6):415-28
pubmed: 12042769
Mol Cell. 2007 Jan 12;25(1):15-30
pubmed: 17218268
Cell. 2012 Jul 6;150(1):12-27
pubmed: 22770212
Sci Rep. 2019 Jun 3;9(1):8189
pubmed: 31160694
Int J Mol Sci. 2017 Feb 23;18(3):
pubmed: 28241481
J Cell Sci. 2003 Dec 15;116(Pt 24):4905-14
pubmed: 14625384
Dermatol Clin. 2007 Oct;25(4):515-23, viii
pubmed: 17903610
Oncol Lett. 2013 Nov;6(5):1295-1298
pubmed: 24179511
Epigenetics. 2009 Jul 1;4(5):302-6
pubmed: 19633430
Curr Treat Options Oncol. 2015 Jan;16(1):318
pubmed: 25750175
BMC Cancer. 2014 Jul 22;14:531
pubmed: 25047223
Steroids. 2013 Feb;78(2):127-36
pubmed: 23178257
Science. 2001 Aug 10;293(5532):1074-80
pubmed: 11498575
Oncogene. 2013 Sep 19;32(38):4586-92
pubmed: 23128397
Gynecol Oncol. 2013 Dec;131(3):772-9
pubmed: 24125749
Ann Surg Oncol. 2008 Jul;15(7):1968-76
pubmed: 18470569
Cancer Res. 2008 Jun 1;68(11):4311-20
pubmed: 18519691
Oncotarget. 2017 Oct 26;8(59):100187-100195
pubmed: 29245970
Ann Med. 2015;47(5):359-69
pubmed: 26158617
Proc Nutr Soc. 2008 May;67(2):115-27
pubmed: 18412986
J Steroid Biochem Mol Biol. 2014 Sep;143:348-56
pubmed: 24726990
Cancer Res. 2009 May 1;69(9):3802-9
pubmed: 19366799
Cancer Res. 2006 May 1;66(9):4929-35
pubmed: 16651450
Int J Cancer. 2010 Nov 15;127(10):2360-6
pubmed: 20162570
J Clin Oncol. 2010 Mar 10;28(8):1358-65
pubmed: 20142597
Dev Cell. 2010 Nov 16;19(5):698-711
pubmed: 21074720
Mol Cell Endocrinol. 2009 Dec 10;313(1-2):1-8
pubmed: 19729047
Nat Rev Cancer. 2007 Sep;7(9):684-700
pubmed: 17721433
Genes Dev. 1996 Jan 15;10(2):142-53
pubmed: 8566748
Onco Targets Ther. 2017 Jun 26;10:3131-3144
pubmed: 28706445
Transcription. 2012 Nov-Dec;3(6):310-4
pubmed: 23117820
Oncol Rep. 2012 Mar;27(3):637-42
pubmed: 22076537
Oncotarget. 2018 Feb 16;9(18):14481-14491
pubmed: 29581858
Biochim Biophys Acta Gene Regul Mech. 2018 Aug;1861(8):697-705
pubmed: 30018005
J Ovarian Res. 2016 Apr 18;9:26
pubmed: 27091127
J Cancer. 2019 Jul 8;10(17):4072-4084
pubmed: 31417652
Cancer Cell. 2008 Jun;13(6):529-41
pubmed: 18538736
Mol Carcinog. 2008 Sep;47(9):701-6
pubmed: 18176935
Nature. 2000 Jan 6;403(6765):41-5
pubmed: 10638745
Int J Cancer. 2000 Apr 1;86(1):40-6
pubmed: 10728592
Oncotarget. 2017 Jun 28;8(40):67553-67566
pubmed: 28978053
Am J Pathol. 2009 May;174(5):1619-28
pubmed: 19349354
Oncogene. 2011 Aug 4;30(31):3391-403
pubmed: 21516126
Cell Rep. 2019 Nov 26;29(9):2659-2671.e6
pubmed: 31775036
Nat Rev Cancer. 2010 Jul;10(7):457-69
pubmed: 20574448
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:3-14
pubmed: 27743768
Nature. 2005 Jun 30;435(7046):1262-6
pubmed: 15988529